The board of the £366.9m Schroder UK Public Private trust is proposing changes to its investment policy to allow the trust to consider global investment, according to the annual report for the trust.
The former Woodford Patient Capital trust has been focused on venture and growth stage UK companies. However, the board now believes shareholders would be better served by benefitting from global investment opportunities, but still in the venture and growth space. "The portfolio manager has unparalleled access to a global universe of top-quality opportunities and we want to be able to leverage this to give our investors exposure to the best venture and growth companies in the world," the Chair said. Only a 'handful' of managers to join Baillie Gifford and Fidelity in race for unlisted...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes